Strs Ohio Makes New Investment in Accendra Health, Inc. $ACH

Strs Ohio purchased a new position in Accendra Health, Inc. (NYSE:ACH) in the 1st quarter, HoldingsChannel reports. The institutional investor purchased 181,200 shares of the company’s stock, valued at approximately $413,000.

Separately, Keybank National Association OH purchased a new position in shares of Accendra Health during the 1st quarter valued at approximately $46,000.

Accendra Health Trading Up 4.2%

Shares of NYSE:ACH opened at $3.44 on Friday. The company has a fifty day moving average of $3.13. The stock has a market cap of $263.44 million, a PE ratio of -0.24, a P/E/G ratio of 5.09 and a beta of 1.58. Accendra Health, Inc. has a 52-week low of $1.84 and a 52-week high of $8.40.

Accendra Health (NYSE:ACH) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.02. The business had revenue of $627.78 million for the quarter. Accendra Health had a negative return on equity of 13.18% and a negative net margin of 39.84%. Analysts predict that Accendra Health, Inc. will post 0.31 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently commented on ACH. Citigroup increased their price objective on Accendra Health from $3.25 to $5.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Weiss Ratings cut shares of Accendra Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, July 1st. Zacks Research upgraded shares of Accendra Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 21st. UBS Group raised their target price on shares of Accendra Health from $3.00 to $4.50 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Finally, Robert W. Baird boosted their target price on Accendra Health from $5.00 to $6.00 and gave the stock an “outperform” rating in a report on Tuesday, May 12th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $5.17.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.